Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $618.88 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $134.64 | 9 | $0 (2022) |
| Novo Nordisk Inc | $125.69 | 4 | $0 (2024) |
| Celgene Corporation | $86.23 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70.58 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $69.06 | 5 | $0 (2021) |
| PFIZER INC. | $43.77 | 4 | $0 (2019) |
| Abbott Laboratories | $39.11 | 2 | $0 (2020) |
| Sanofi Pasteur Inc. | $36.57 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $13.23 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.63 | 2 | Novo Nordisk Inc ($34.63) |
| 2023 | $16.97 | 1 | Novo Nordisk Inc ($16.97) |
| 2022 | $17.53 | 1 | GlaxoSmithKline, LLC. ($17.53) |
| 2021 | $11.59 | 1 | Merck Sharp & Dohme Corporation ($11.59) |
| 2020 | $11.47 | 1 | Abbott Laboratories ($11.47) |
| 2019 | $355.35 | 12 | Celgene Corporation ($86.23) |
| 2018 | $143.38 | 9 | GlaxoSmithKline, LLC. ($52.02) |
| 2017 | $27.96 | 2 | GlaxoSmithKline, LLC. ($27.96) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Diabetes | ||||||
| 10/05/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes | ||||||
| 07/20/2022 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: VACCINES | ||||||
| 06/03/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), ROTATEQ, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: VACCINE | ||||||
| 09/15/2020 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Diabetes Care | ||||||
| 11/15/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/13/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $86.23 | General |
| Category: Dermatology | ||||||
| 08/27/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $74.09 | General |
| 08/16/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: VACCINES | ||||||
| 08/01/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: DERMATOLOGY | ||||||
| 07/10/2019 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/30/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: VACCINE | ||||||
| 05/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $70.58 | General |
| Category: DIABETES | ||||||
| 04/18/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: VACCINES | ||||||
| 03/25/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: VACCINE | ||||||
| 10/04/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/27/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), FLUZONE QUADRIVALENT | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: VACCINES | ||||||
| 07/05/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 352 | 586 | $130,401 | $36,591 |
| 2022 | 7 | 375 | 557 | $80,636 | $33,972 |
| 2021 | 10 | 391 | 582 | $52,407 | $37,721 |
| 2020 | 8 | 335 | 495 | $37,986 | $27,876 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 199 | $58,305 | $11,324 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 189 | $19,117 | $10,823 | 56.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 49 | 49 | $19,365 | $5,984 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 79 | $5,211 | $3,412 | 65.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 27 | $14,849 | $2,579 | 17.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 28 | 30 | $8,816 | $1,732 | 19.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 12 | 13 | $4,738 | $737.10 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 205 | $21,000 | $11,939 | 56.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 56 | 158 | $28,014 | $8,419 | 30.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 35 | 35 | $9,675 | $4,441 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 93 | $6,317 | $4,127 | 65.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 34 | 36 | $6,153 | $1,940 | 31.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 19 | $7,825 | $1,888 | 24.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 11 | $1,653 | $1,218 | 73.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 137 | 199 | $20,045 | $12,425 | 62.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 65 | 186 | $13,269 | $10,194 | 76.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 40 | 40 | $5,327 | $5,138 | 96.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 69 | $4,713 | $3,075 | 65.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 29 | 31 | $3,276 | $2,439 | 74.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $1,487 | $1,173 | 78.9% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 11 | 11 | $1,470 | $1,102 | 75.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 11 | 11 | $1,094 | $843.92 | 77.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 12 | 12 | $864.36 | $666.96 | 77.2% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 11 | 12 | $860.16 | $663.72 | 77.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 69 | 185 | $13,318 | $10,284 | 77.2% |
About Dr. Janet Barkhou, MD
Dr. Janet Barkhou, MD is a Family Medicine healthcare provider based in Janesville, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2017. The National Provider Identifier (NPI) number assigned to this provider is 1144752528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Janet Barkhou, MD has received a total of $618.88 in payments from pharmaceutical and medical device companies, with $34.63 received in 2024. These payments were reported across 29 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($618.88).
As a Medicare-enrolled provider, Barkhou has provided services to 1,453 Medicare beneficiaries, totaling 2,220 services with total Medicare billing of $136,160. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Janesville, WI
- Active Since 04/03/2017
- Last Updated 06/25/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1144752528
Products in Payments
- Otezla (Drug) $86.23
- JARDIANCE (Drug) $70.58
- Ozempic (Drug) $51.60
- PNEUMOVAX 23 (Biological) $42.77
- BEXSERO (Biological) $41.04
- FLUZONE HIGH-DOSE (Drug) $36.57
- BREO (Drug) $34.32
- ANORO (Drug) $31.32
- BREO ELLIPTA (Drug) $27.96
- CardioMEMS HF System (Device) $27.64
- ELIQUIS (Drug) $21.81
- JANUVIA (Drug) $14.70
- BRILINTA (Drug) $13.23
- GARDASIL 9 (Biological) $11.59
- FreeStyle Libre (Device) $11.47
- EUCRISA (Drug) $11.09
- CHANTIX (Drug) $10.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Janesville
Dr. Timothy Reid, Md, MD
Family Medicine — Payments: $247,508
Dr. Daniel Kulas, Md, MD
Family Medicine — Payments: $1,360
Divya Sharma, Md, MD
Family Medicine — Payments: $1,247
Dr. Jason Welch, Md, MD
Family Medicine — Payments: $1,125
Jane Anderson, Md, MD
Family Medicine — Payments: $965.42
Dr. Ronald Bowers, Md, MD
Family Medicine — Payments: $675.21